RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ANGELUCCI E
Collezione AOU Alessandria

Items : 4

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Galieni P; Rigacci L; Pinto A; Fava C; Candoni A; Venditti A; Federici AB; Musto P; Marchesi F; Gentile M; Bocchia M; Olivieri A; Di Renzo N; Ferrandina C; Ortu La Barbera E; Selleri C; Scattolin AM; Luppi M; et alii...

High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2). in Haematologica / Haematologica. 2020 Nov 1;105(11):2671-2674. doi: 10.3324/haematol.2019.235705.

2020
AOU Alessandria
AOU Città della Salute di Torino

Della Starza I; Del Giudice I; Cuneo A; Albano F; Neri A; Vignetti M; Piciocchi A; Nanni M; Musolino C; Del Poeta G; Battistini R; Gozzetti A; Pietrasanta D; Reda G; Tedeschi A; Liberati AM; Re F; Angelucci E; Zaja F; Coscia M; Ilariucci F; Soddu S; Molica S; Mauro FR; De Propris MS; Raponi S; Guarini AR; Foà R;

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab. in Bone marrow transplantation / Bone Marrow Transplant. 2020 Aug;55(8):1580-1587. doi: 10.1038/s41409-020-0855-z. Epub 2020 Mar 13.

2020
AOU Alessandria

Bacigalupo A; Angelucci E; Raiola AM; Varaldo R; Di Grazia C; Gualandi F; Benedetti E; Risitano A; Musso M; Zallio F; Ciceri F; Chiusolo P; Sica S; Rambaldi A; Bonifazi F; Parma M; Martino M; Onida F; Iori AP; Selleri C; Borghero C; Bertaina A; Prezioso L; Algeri M; Locatelli F;

Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi. in Haematologica / Haematologica. 2018 Aug;103(8):1345-1350. doi: 10.3324/haematol.2017.186569. Epub 2018 May 10.

2018
AOU Alessandria

Storti S; Spina M; Pesce EA; Salvi F; Merli M; Ruffini A; Cabras G; Chiappella A; Angelucci E; Fabbri A; Liberati AM; Tani M; Musuraca G; Molinari A; Petrilli MP; Palladino C; Ciancia R; Ferrario A; Gasbarrino C; Monaco F; Fraticelli V; De Vellis A; Merli F; Luminari S;